Panax ginseng is superior to vitamin E as a hepatoprotector against cyclophosphamide-induced liver damage. (October 2019)
- Record Type:
- Journal Article
- Title:
- Panax ginseng is superior to vitamin E as a hepatoprotector against cyclophosphamide-induced liver damage. (October 2019)
- Main Title:
- Panax ginseng is superior to vitamin E as a hepatoprotector against cyclophosphamide-induced liver damage
- Authors:
- Abdelfattah-Hassan, Ahmed
Shalaby, Shimaa I.
Khater, Safaa I.
El-Shetry, Eman S.
Abd El Fadil, Hosny
Elsayed, Shafika A. - Abstract:
- Graphical abstract: Highlights: Cyclophoshpamide clinical application lead to multiple non-target-organ damage. Liver-damage occurs by oxidative stress and induction of apoptosis. P. ginseng protected the liver by reducing oxidative stress, inflammation and apoptosis. P. ginseng was more potent that vitamin E (a strong antioxidant). Abstract: Background and aims: Cyclophosphamide (CPh) is a frequently used drug, in human and animals for its immunosuppressive and anticancer potential. However, it is metabolized by the liver yielding damaging toxicants (to the liver itself and other non-target vital organs) via oxidative stress, apoptosis induction and finally necrosis. Since there is no escaping of using such harmful medications, we focused on alleviating its side-effects. Panax ginseng Meyer is a potent candidate, and we still lack adequate information on its hepatoprotective role against cyclophosphamide-induced liver-damage. Methods: Here, we used P. ginseng (Korean Red Ginseng) compared to vitamin-E (natural antioxidant) in combating CPh-induced liver damage. Forty-eight albino rats were divided into 6 groups, Control, Ginseng, Vitamin E, Cyclophosphamide (CPh), CPh + Ginseng or CPh + Vitamin-E. Blood samples were taken for biochemical analyses and liver samples were collected for histopathology, oxidative stress evaluation, and gene expression analyses. Results: In CPh group, typical CPh-liver damage was evident (higher levels of AST, ALT, ALP; lower albumin and totalGraphical abstract: Highlights: Cyclophoshpamide clinical application lead to multiple non-target-organ damage. Liver-damage occurs by oxidative stress and induction of apoptosis. P. ginseng protected the liver by reducing oxidative stress, inflammation and apoptosis. P. ginseng was more potent that vitamin E (a strong antioxidant). Abstract: Background and aims: Cyclophosphamide (CPh) is a frequently used drug, in human and animals for its immunosuppressive and anticancer potential. However, it is metabolized by the liver yielding damaging toxicants (to the liver itself and other non-target vital organs) via oxidative stress, apoptosis induction and finally necrosis. Since there is no escaping of using such harmful medications, we focused on alleviating its side-effects. Panax ginseng Meyer is a potent candidate, and we still lack adequate information on its hepatoprotective role against cyclophosphamide-induced liver-damage. Methods: Here, we used P. ginseng (Korean Red Ginseng) compared to vitamin-E (natural antioxidant) in combating CPh-induced liver damage. Forty-eight albino rats were divided into 6 groups, Control, Ginseng, Vitamin E, Cyclophosphamide (CPh), CPh + Ginseng or CPh + Vitamin-E. Blood samples were taken for biochemical analyses and liver samples were collected for histopathology, oxidative stress evaluation, and gene expression analyses. Results: In CPh group, typical CPh-liver damage was evident (higher levels of AST, ALT, ALP; lower albumin and total proteins levels; lower liver tissue concentrations of SOD, GPX and CAT and higher MDA; injured liver histopathological picture; and finally increased TNF-α, IL-1β and Caspase3 and decreased BCL-2 genes expression). All these were abolished with either P. ginseng or vitamin-E administration. However, P. ginseng was overall superior to vitamin-E, especially in restoring blood biochemical findings and damaged histopathological picture. Conclusions: Therefore, P. ginseng is a potent hepatoprotector (vitamin-E to a lesser extent) and should be considered where liver damage is expected secondary to damaging medications; as cyclophosphamide. … (more)
- Is Part Of:
- Complementary therapies in medicine. Volume 46(2019)
- Journal:
- Complementary therapies in medicine
- Issue:
- Volume 46(2019)
- Issue Display:
- Volume 46, Issue 2019 (2019)
- Year:
- 2019
- Volume:
- 46
- Issue:
- 2019
- Issue Sort Value:
- 2019-0046-2019-0000
- Page Start:
- 95
- Page End:
- 102
- Publication Date:
- 2019-10
- Subjects:
- Panax ginseng Meyer -- Oxazaphosphorines -- Acrolein -- Oxidative stress -- Inflammation -- Apoptosis
Alternative medicine -- Periodicals
Complementary Therapies -- Periodicals
Médecines parallèles -- Périodiques
Thérapeutique -- Périodiques
Alternative medicine
Electronic journals
Periodicals
615.5 - Journal URLs:
- http://www.sciencedirect.com/science/journal/09652299 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.ctim.2019.08.005 ↗
- Languages:
- English
- ISSNs:
- 0965-2299
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3364.203750
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 11809.xml